International patent granted to Capsulution NanoScience AG covering the manufacture of novel nano- and micro-capsules
Berlin (April 27, 2004) - After having been granted an international patent in the US in mid-April (patent No.: US 6,699,501) Berlin-based Capsulution NanoScience AG - a specialist in the development of innovative solutions for improved drug-delivery - secured important rights for the further development and commercialisation of its proprietary technology. The claimed IP is a fundamental patent covering the manufacture of novel nano- and microcapsules by means of the so-called Layer-by-Layer technology (LBL-Technology®). The now-granted patent claims the encapsulation of biological entities, e.g. liposomes, for the manufacture of improved pharmaceutical formulations. The patent also covers the encapsulation and layering of other biological particles such as bacteria or yeast cells and single cell organisms possessing cell walls. Particles that are encapsulated this way will have numerous applications: in innovative drugs, in functional foods or in novel cosmetic products.

To Capsulution this represents an important patent from a range of patent families, which the company had in-licensed exclusively for worldwide marketing from Garching Innovation GmbH - the technology transfer office of the Max Planck Society. In addition to these, Capsulution in recent years filed further patent applications regarding newly developed applications of the LBL-Technology®. By means of this technology capsules are manufactured by the layerwise adsorption of polyelectrolytes onto the encapsulated compounds.

Dr. Andreas Voigt, CSO of Capsulution said: "The recently granted patent further sharpens our competitive edge as a developer of innovative nano- and micro-capsules for high-end applications in the fields of drug-delivery. We are also confident to identify further fields of application where the use of novel capsules with non-spherical shapes will lead to substantially increased benefits." In line with Capsulution's corporate strategy several further developments of this technology are to be protected by patent applications in coming years.

282 words/2,028 characters

Capsulution NanoScience AG:
Capsulution NanoScience AG develops innovative nano- and micron-sized capsules. The company applies its worldwide-patented so-called LBL-Technology®. Based on their minute size, their functionality and their highly reproducible production process the capsules can be used for a multitude of different applications. Accordingly, the precisely sized capsules (500 nm to 50 µm) can be made to function in a manner to suit the intended application, and can be given the appropriate biochemical, electrical, optical and magnetic properties as required by the customer. The capsules can be applied for the delivery of drugs, in cosmetic products, and in diagnostics. Today, the Berlin-based company has 16 highly qualified employees. Amongst Capsulution's clients and partners are key industry players such as Bayer AG, Gelita, SCA Hygiene Products, Cognis, OctoPlus and other renowned companies.


Further information:
Capsulution NanoScience AG
Alexander Herrmann (CFO)
Volmerstr. 7b
D- 12489 Berlin, Germany
Tel.: +49-(0)30-63923627
Fax.: +49-(0)30-63923601
Web: www.capsulution.com 
eMail: alexander.herrmann@capsulution.com 


© BIOCOMMUNICATIONS.net GmbH, Brunnenstr. 128, D-13355 Berlin, Germany - Reprint free of charge. Please supply copy.